标题
The significance of FOXP1 in diffuse large B-cell lymphoma
作者
关键词
-
出版物
LEUKEMIA & LYMPHOMA
Volume 58, Issue 5, Pages 1037-1051
出版商
Informa UK Limited
发表日期
2016-09-28
DOI
10.1080/10428194.2016.1228932
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The hematopoietic oncoprotein FOXP1 promotes tumor cell survival in diffuse large B-cell lymphoma by repressing S1PR2 signaling
- (2016) M. Flori et al. BLOOD
- N-terminally truncated FOXP1 protein expression and alternate internal FOXP1 promoter usage in normal and malignant B cells
- (2016) P. J. Brown et al. HAEMATOLOGICA
- Subtype-specific addiction of the activated B-cell subset of diffuse large B-cell lymphoma to FOXP1
- (2016) Joseph D. Dekker et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- FOXP2-positive diffuse large B-cell lymphomas exhibit a poor response to R-CHOP therapy and distinct biological signatures
- (2016) Kah Keng Wong et al. Oncotarget
- N-terminally truncated FOXP1 protein expression and alternate internal FOXP1 promoter usage in normal and malignant B cells
- (2016) P. J. Brown et al. HAEMATOLOGICA
- Triple-hit B-cell Lymphoma With MYC, BCL2, and BCL6 Translocations/Rearrangements
- (2015) Wei Wang et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- The forkhead transcription factor FOXP1 represses human plasma cell differentiation
- (2015) M. van Keimpema et al. BLOOD
- Aggressive B cell Lymphoma: Optimal Therapy for MYC-positive, Double-Hit, and Triple-Hit DLBCL
- (2015) Kieron Dunleavy CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Low HIP1R mRNA and protein expression are associated with worse survival in diffuse large B-cell lymphoma patients treated with R-CHOP
- (2015) Kah Keng Wong et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Multiparameter analysis of homogeneously R-CHOP-treated diffuse large B cell lymphomas identifies CD5 and FOXP1 as relevant prognostic biomarkers: report of the prospective SAKK 38/07 study
- (2015) Alexandar Tzankov et al. Journal of Hematology & Oncology
- Recurrent genomic rearrangements in primary testicular lymphoma
- (2015) David DW Twa et al. JOURNAL OF PATHOLOGY
- Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL Consortium
- (2015) L Deng et al. LEUKEMIA
- Different biological risk factors in young poor-prognosis and elderly patients with diffuse large B-cell lymphoma
- (2015) H Horn et al. LEUKEMIA
- FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas
- (2015) P J Brown et al. LEUKEMIA
- FOXP1 potentiates Wnt/β-catenin signaling in diffuse large B cell lymphoma
- (2015) Matthew P. Walker et al. Science Signaling
- B-Cell Receptor Signaling in Diffuse Large B-Cell lymphoma
- (2015) Ryan M. Young et al. SEMINARS IN HEMATOLOGY
- A novel FOXP1-PDGFRA fusion gene in myeloproliferative neoplasm with eosinophilia
- (2015) Yuka Sugimoto et al. Cancer Genetics
- Uncovering MicroRNA Regulatory Hubs that Modulate Plasma Cell Differentiation
- (2015) Dong-Yan Tsai et al. Scientific Reports
- FOXP1 potentiates Wnt/β-catenin signaling in diffuse large B cell lymphoma
- (2015) Matthew P. Walker et al. Science Signaling
- miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1
- (2014) M. Mraz et al. BLOOD
- FOXP1 directly represses transcription of proapoptotic genes and cooperates with NF- B to promote survival of human B cells
- (2014) M. van Keimpema et al. BLOOD
- Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity
- (2014) Laurie H. Sehn et al. BLOOD
- FOXP1inhibits cell growth and attenuates tumorigenicity of neuroblastoma
- (2014) Sandra Ackermann et al. BMC CANCER
- Transforming Growth Factor β-Mediated Suppression of Antitumor T Cells Requires FoxP1 Transcription Factor Expression
- (2014) Tom L. Stephen et al. IMMUNITY
- Transcriptional Regulation by FOXP1, FOXP2, and FOXP4 Dimerization
- (2014) Cora Sin et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Integrative Analysis of FOXP1 Function Reveals a Tumor-Suppressive Effect in Prostate Cancer
- (2014) Ken-ichi Takayama et al. MOLECULAR ENDOCRINOLOGY
- Loss of signalling via Gα13 in germinal centre B-cell-derived lymphoma
- (2014) Jagan R. Muppidi et al. NATURE
- Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1
- (2014) Leila Rouhigharabaei et al. PLoS One
- Immunohistochemical and Molecular Characteristics with Prognostic Significance in Diffuse Large B-Cell Lymphoma
- (2014) Carmen Bellas et al. PLoS One
- Downregulation of FOXP1 is required during germinal center B-cell function
- (2013) A. Sagardoy et al. BLOOD
- The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis
- (2013) Z. R. Hunter et al. BLOOD
- FOXP1 acts through a negative feedback loop to suppress FOXO-induced apoptosis
- (2013) R van Boxtel et al. CELL DEATH AND DIFFERENTIATION
- Poor Concordance among Nine Immunohistochemistry Classifiers of Cell-of-Origin for Diffuse Large B-Cell Lymphoma: Implications for Therapeutic Strategies
- (2013) R. Coutinho et al. CLINICAL CANCER RESEARCH
- Prognostic significance of miR-34a and its target proteins of FOXP1, p53, and BCL2 in gastric MALT lymphoma and DLBCL
- (2013) Miaoxia He et al. Gastric Cancer
- Prognostic significance of immunohistochemistry-based markers and algorithms in immunochemotherapy-treated diffuse large B cell lymphoma patients
- (2013) Rachel E Culpin et al. HISTOPATHOLOGY
- Reciprocal expression of the endocytic protein HIP1R and its repressor FOXP1 predicts outcome in R-CHOP-treated diffuse large B-cell lymphoma patients
- (2013) K K Wong et al. LEUKEMIA
- FoxP1 Stimulates Angiogenesis by Repressing the Inhibitory Guidance Protein Semaphorin 5B in Endothelial Cells
- (2013) Sebastian Grundmann et al. PLoS One
- Role of microRNAs and microRNA machinery in the pathogenesis of diffuse large B-cell lymphoma
- (2013) S Caramuta et al. Blood Cancer Journal
- Both FOXP1 and p65 expression are adverse risk factors in diffuse large B-cell lymphoma: A retrospective study in China
- (2012) Cheng-Ru Hu et al. ACTA HISTOCHEMICA
- Inter- and intra-observational variability in immunohistochemistry: a multicentre analysis of diffuse large B-cell lymphoma staining
- (2012) Charles H Lawrie et al. HISTOPATHOLOGY
- Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
- (2012) C Visco et al. LEUKEMIA
- Serum microRNAs are promising novel biomarkers for diffuse large B cell lymphoma
- (2011) Cheng Fang et al. ANNALS OF HEMATOLOGY
- Partial plasma cell differentiation as a mechanism of lost major histocompatibility complex class II expression in diffuse large B-cell lymphoma
- (2011) S. T. Wilkinson et al. BLOOD
- The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications
- (2011) E. Campo et al. BLOOD
- Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1
- (2011) V. J. Craig et al. BLOOD
- Identification of FOXP1 and SNX2 as novel ABL1 fusion partners in acute lymphoblastic leukaemia
- (2011) Thomas Ernst et al. BRITISH JOURNAL OF HAEMATOLOGY
- MicroRNAs Are Independent Predictors of Outcome in Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP
- (2011) A. J. Alencar et al. CLINICAL CANCER RESEARCH
- The Germinal Center/Activated B-Cell Subclassification Has a Prognostic Impact for Response to Salvage Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Bio-CORAL Study
- (2011) Catherine Thieblemont et al. JOURNAL OF CLINICAL ONCOLOGY
- FOXP1 expression and its clinicopathologic significance in nodal and extranodal diffuse large B-cell lymphoma
- (2010) BaoHua Yu et al. ANNALS OF HEMATOLOGY
- FOXP1 protein overexpression is associated with inferior outcome in nodal diffuse large B-cell lymphomas with non-germinal centre phenotype, independent of gains and structural aberrations at 3p14.1
- (2010) Sylvia Hoeller et al. HISTOPATHOLOGY
- MicroRNA-34a Perturbs B Lymphocyte Development by Repressing the Forkhead Box Transcription Factor Foxp1
- (2010) Dinesh S. Rao et al. IMMUNITY
- Immunohistochemical Methods for Predicting Cell of Origin and Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab
- (2010) Paul N. Meyer et al. JOURNAL OF CLINICAL ONCOLOGY
- Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
- (2010) R. Eric Davis et al. NATURE
- A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy
- (2009) W. W.L. Choi et al. CLINICAL CANCER RESEARCH
- Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas
- (2009) Heidi Nyman et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Immunophenotypic Analysis of AIDS-Related Diffuse Large B-Cell Lymphoma and Clinical Implications in Patients From AIDS Malignancies Consortium Clinical Trials 010 and 034
- (2009) Amy Chadburn et al. JOURNAL OF CLINICAL ONCOLOGY
- Immuno–Fluorescence In Situ Hybridization Index Predicts Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP: A GELA Study
- (2009) Christiane Copie-Bergman et al. JOURNAL OF CLINICAL ONCOLOGY
- miRNA profiling of B-cell subsets: specific miRNA profile for germinal center B cells with variation between centroblasts and centrocytes
- (2009) Lu Ping Tan et al. LABORATORY INVESTIGATION
- Relative abundance of full-length and truncated FOXP1 isoforms is associated with differential NFκB activity in Follicular Lymphoma
- (2009) Michael R. Green et al. LEUKEMIA RESEARCH
- Prognostic impact of activated B-cell focused classification in diffuse large B-cell lymphoma patients treated with R-CHOP
- (2009) Heidi Nyman et al. MODERN PATHOLOGY
- New time-dependent approach to analyse the prognostic significance of immunohistochemical biomarkers in colon cancer and diffuse large B-cell lymphoma
- (2008) H Adams et al. JOURNAL OF CLINICAL PATHOLOGY
- The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximab
- (2008) J-P Jais et al. LEUKEMIA
- FOXP1 abnormalities in lymphoma: translocation breakpoint mapping reveals insights into deregulated transcriptional control
- (2008) Alison Goatly et al. MODERN PATHOLOGY
- Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways
- (2008) G. Lenz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More